Complete advanced imaging scans to help detect your cancer more accurately

Back to Hepatocellular Carcinoma (HCC) trials

Recruiting

What is this trial?

This trial is testing whether combining multiple PET imaging scans — each using different tracers to highlight different aspects of your cancer — can give doctors a more complete picture of your disease. Patients with liver cancer (hepatocellular carcinoma) or certain neuroendocrine cancers of the pancreas and digestive tract will receive these combined imaging scans to see if this approach helps doctors better understand their cancer and plan treatment.

Currently, doctors typically use one imaging scan at a time for each type of cancer, which may miss important information about how aggressive the cancer is or where it has spread. This study aims to show that using multiple complementary scans together provides a more accurate and complete view of the cancer, which could lead to better treatment decisions and outcomes.

Do you qualify?

You likely qualify if…

you are at least 18 years old
you have been diagnosed with liver cancer (hepatocellular carcinoma) or a neuroendocrine tumor of the pancreas or digestive tract, confirmed by biopsy
you have at least one tumor that can be measured on a recent CT or MRI scan (performed within 6 months)
you are in generally good health (ECOG performance score of 2 or lower, meaning you can do most daily activities)
you are affiliated with the French social security system
if you are a woman of childbearing potential, you have a negative pregnancy test and agree to use reliable contraception for 6 months after the imaging scans

You likely don't qualify if…

you are allergic to gallium-68, fluorine-18, or contrast dyes used in imaging
you have had major surgery within the past 4 weeks
you have other active cancers (except non-melanoma skin cancer or cervical cancer in situ treated more than 2 years ago)
you are pregnant or breastfeeding
you have an uncontrolled serious medical or psychiatric condition that would make participation unsafe

What participation looks like

If you enroll, you will undergo multiple specialized PET imaging scans on the same day or over a few visits at one of the participating hospitals in France. Each scan uses a different tracer to highlight different characteristics of your cancer. The scans are non-invasive — you receive an injection of the tracer, wait a short time, then lie still in the imaging machine for about 20–30 minutes per scan. There are no additional treatments involved; this is purely a diagnostic imaging study to help your doctors understand your cancer better.

Testing new imaging scans to better detect liver and pancreatic cancers

What is this trial?

Do you qualify?

What participation looks like

Trial locations(3 sites)